1. Hillis LD, Braunwald E. Coronary-artery spasm. N Engl J Med. 1978. 299:695–702.
2. Maseri A, L'Abbate A, Baroldi G, et al. Coronary vasospasm as a possible cause of myocardial infarction: a conclusion derived from the study of "preinfarction" angina. N Engl J Med. 1978. 299:1271–1277.
3. Sueda S, Ochi N, Kawada H, et al. Frequency of provoked coronary vasospasm in patients undergoing coronary arteriography with spasm provocation test of acetylcholine. Am J Cardiol. 1999. 83:1186–1190.
4. Shimokawa H, Nagasawa K, Irie T, et al. Clinical characteristics and long-term prognosis of patients with variant angina: a comparative study between western and Japanese populations. Int J Cardiol. 1988. 18:331–349.
5. Pristipino C, Beltrame JF, Finocchiaro ML, et al. Major racial differences in coronary constrictor response between Japanese and Caucasians with recent myocardial infarction. Circulation. 2000. 101:1102–1108.
6. Caralis DG, Deligonul U, Kern MJ, Cohen JD. Smoking is a risk factor for coronary spasm in young women. Circulation. 1992. 85:905–909.
7. Sugiishi M, Takatsu F. Cigarette smoking is a major risk factor for coronary spasm. Circulation. 1993. 87:76–79.
8. Nobuyoshi M, Abe M, Nosaka H, et al. Statistical analysis of clinical risk factors for coronary artery spasm: identification of the most important determinant. Am Heart J. 1992. 124:32–38.
9. Takaoka K, Yoshimura M, Ogawa H, et al. Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking. Int J Cardiol. 2000. 72:121–126.
10. Cheon BW, Rha SW, Wani SP, et al. Impact of smoking and smoking-related parameters on acetylcholine-induced coronary artery spasm. Korean Circ J. 2006. 36:661–665.
11. Ong P, Athanasiadis A, Hill S, Vogelsberg H, Voehringer M, Sechtem U. Coronary artery spasm as a frequent cause of acute coronary syndrome. J Am Coll Cardiol. 2008. 52:523–527.
12. Lee HC, Hong SR, Kim HS, et al. The risk factors of vasospastic angina. Korean Circ J. 2002. 32:224–232.
13. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease: report of the Ad Hoc Committee for grading of coronary artery disease, council on cardiovascular surgery, American Heart Association. Circulation. 1975. 51:Suppl 4. 5–40.
14. Report on the social statistics survey, 2006. Korea National Statistics Office. Available from:
http://www.nso.go.kr/.
15. Sueda S, Suzuki J, Watanabe K, et al. Clinical characteristics of female patients with coronary spastic angina: comparison with male patients. Jpn Circ J. 2000. 64:416–420.
16. Goldberg DM, Hahn SE, Parkes JG. Beyond alcohol: beverage consumption and cardiovascular mortality. Clin Chim Acta. 1995. 237:155–187.
17. Takizawa A, Yasue H, Omote S, et al. Variant angina induced by alcohol ingestion. Am Heart J. 1984. 107:25–27.
18. Akasaka T, Yoshida K, Hozumi T, et al. Comparison of coronary flow reserve between focal and diffuse vasoconstriction induced by ergonovine in patients with vasospastic angina. Am J Cardiol. 1997. 80:705–710.
19. Sueda S, Kohno H, Fukuda H, et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations. Coron Artery Dis. 2004. 15:491–497.
20. Song JK, Park SW, Kang DH, et al. Safety and clinical impact of ergonovine stress echocardiography for diagnosis of coronary vasospasm. J Am Coll Cardiol. 2000. 35:1850–1856.
21. Kim PJ, Seung KB, Kim DB, et al. Clinical and angiographic characteristics of acute myocardial infarction caused by vasospastic angina without organic coronary heart disease. Circ J. 2007. 71:1383–1386.
22. Sueda S, Izoe Y, Kohno H, Fukuda H, Uraoka T. Need for documentation of guidelines for coronary artery spasm: an investigation by questionnaire in Japan. Circ J. 2005. 69:1333–1337.